Details for New Drug Application (NDA): 065111
✉ Email this page to a colleague
The generic ingredient in KANAMYCIN SULFATE is kanamycin sulfate. There are five drug master file entries for this compound. Additional details are available on the kanamycin sulfate profile page.
Summary for 065111
Tradename: | KANAMYCIN SULFATE |
Applicant: | Fresenius Kabi Usa |
Ingredient: | kanamycin sulfate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 065111
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/2ML | ||||
Approval Date: | Dec 17, 2002 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/3ML | ||||
Approval Date: | Dec 17, 2002 | TE: | RLD: | No |
Complete Access Available with Subscription